Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
|
|
Gene Biotherapeutics, Inc. (CRXM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 04/23/2021 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 07/28/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 12/29/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 05/22/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 04/15/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 04/05/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/30/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 04/15/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 03/16/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 03/26/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/14/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
| 04/13/1999 |
10-K
| Annual Report for the period ended September 30, 1998 |
| 12/23/1997 |
10-K
| Annual Report for the period ended September 30, 1997 |
| 01/13/1997 |
10-K
| Annual Report for the period ended September 30, 1996 |
|
|